Core Viewpoint - The company has indicated that it offers medications that can treat viral infections such as influenza and bacterial infections, addressing concerns raised by investors regarding the current outbreak of diseases like chikungunya and influenza [2] Company Summary - The company, Prolo Pharmaceutical (000739.SZ), has stated that its products, including Oseltamivir and Amantadine, are effective against influenza viruses [2] - The company also provides a range of antibiotics such as Cefixime, Cefdinir, and Amoxicillin/Clavulanate Potassium for infection treatment [2]